Conventional treatment

Increasing knowledge of the molecular and biochemical basis
of genetic disorders will lead to better prospects for therapeutic
intervention and even the possibility of prenatal treatment in
some disorders. In the future, treatment of common
multifactorial disorders may be improved if genotype analysis of
affected individuals identifies those who are likely to respond to
particular drugs. In most single gene disorders, the primary
defect is not yet amenable to specific treatment. Conventional
treatment aimed at relieving the symptoms and preventing
complications remains important and may require a
multidisciplinary approach. Management of Duchenne
muscular dystrophy, for example, includes neurological and
orthopaedic assessment and treatment, physiotherapy,
treatment of chest infections and heart failure, mobility aids,
home modifications, appropriate schooling, and support for
the family, all of which aim to lessen the burden of the
disorder. Lay organisations often provide additional support for
the patients and their families. The Muscular Dystrophy
Organisation, for example, provides information leaflets,
supports research, and employs family care officers who work
closely with families and the medical services.